Start the beta blockers in hospitalized CHF

In patients hospitalized with systolic CHF, those that had beta blockers initiated during their hospital stay were much less likely to die (adjusted HR 0.77, CI 0.68-0.87) or be readmitted within a year (adjusted HR 0.89, CI 0.80-0.99) than those who did not have beta blockers initiated. There was no benefit found for those with preserved systolic function (abstract). In patients not already on a beta-blocker, they should be initiated on one (unless contraindicated), especially those with systolic dysfunction.

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment